{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:41:21Z","timestamp":1790505681056,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["medical-hypotheses.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.mehy.2013.12.019","type":"journal-article","created":{"date-parts":[[2014,1,14]],"date-time":"2014-01-14T03:46:11Z","timestamp":1389671171000},"page":"319-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Role of vacuolar ATPase and Skp1 in Sj\u00f6gren\u2019s syndrome"],"prefix":"10.1016","volume":"82","author":[{"given":"Pulukool","family":"Sandhya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debashish","family":"Danda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2013.12.019_b0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaut.2012.01.002","article-title":"Pathogenesis of Sj\u00f6gren\u2019s syndrome: what we know and what we should learn","volume":"39","author":"Tzioufas","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.mehy.2013.12.019_b0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jaut.2010.06.012","article-title":"Activation of the type interferon pathway in primary Sjogren\u2019s syndrome","volume":"35","author":"Mavragani","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.mehy.2013.12.019_b0015","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/ard.2004.025676","article-title":"Primary Sj\u00f6gren\u2019s syndrome: new clinical and therapeutic concepts","volume":"64","author":"Ramos-Casals","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.mehy.2013.12.019_b0020","first-page":"3","article-title":"Sj\u00f6gren\u2019s syndrome: mechanisms of pathogenesis involve interaction of immune and neurosecretory systems","volume":"116","author":"Fox","year":"2002","journal-title":"Scand J Rheumatol Suppl"},{"key":"10.1016\/j.mehy.2013.12.019_b0025","doi-asserted-by":"crossref","first-page":"407031","DOI":"10.1155\/2011\/407031","article-title":"Dysfunction of lacrimal and salivary glands in Sj\u00f6gren\u2019s syndrome: nonimmunologic injury in preinflammatory phase and mouse model","volume":"2011","author":"Hayashi","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.mehy.2013.12.019_b0030","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/rheumatology\/kel067","article-title":"Sjogrens syndrome \u2013 the non-apoptotic model of glandular hypofunction","volume":"45","author":"Dawson","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.mehy.2013.12.019_b0035","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.1021\/bi100397s","article-title":"Regulation and isoform function of the V-ATPases","volume":"49","author":"Toei","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.mehy.2013.12.019_b0040","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/jmg.39.11.796","article-title":"Novel ATP6V1B1 and ATP6V0A4 mutations in autosomal recessive distal renal tubular acidosis with new evidence for hearing loss","volume":"39","author":"Stover","year":"2002","journal-title":"J Med Genet"},{"key":"10.1016\/j.mehy.2013.12.019_b0045","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1681\/ASN.V32264","article-title":"Absence of H(+)-ATPase in cortical collecting tubules of a patient with Sjogren\u2019s syndrome and distal renal tubular acidosis","volume":"3","author":"Cohen","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.mehy.2013.12.019_b0050","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1681\/ASN.V62295","article-title":"Absence of vacuolar H(+)-ATPase pump in the collecting duct of a patient with hypokalemic distal renal tubular acidosis and Sj\u00f6gren\u2019s syndrome","volume":"6","author":"DeFranco","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.mehy.2013.12.019_b0055","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1046\/j.1471-4159.1998.71020630.x","article-title":"Enhanced acetylcholine release from cells that have more 15-kDa proteolipid in their membrane, a constituent V-ATPase, and mediatophore","volume":"71","author":"Isra\u00ebl","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.mehy.2013.12.019_b0060","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0248-4900(03)00075-3","article-title":"Neurotransmitter release: the dark side of the vacuolar-H+ATPase","volume":"95","author":"Morel","year":"2003","journal-title":"Biol Cell"},{"key":"10.1016\/j.mehy.2013.12.019_b0065","first-page":"1552","article-title":"Pure sensory neuropathy in primary Sj\u00f6gren\u2019s syndrome. Longterm prospective followup and review of the literature","volume":"30","author":"Font","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.mehy.2013.12.019_b0205","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/01.md.0000141099.53742.16","article-title":"Neurologic manifestations in primary Sj\u00f6gren syndrome: a study of 82 patients","volume":"83","author":"Delalande","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.mehy.2013.12.019_b0075","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0889-857X(05)70177-0","article-title":"Neuroendocrine manifestations in Sj\u00f6gren\u2019s syndrome","volume":"26","author":"Johnson","year":"2000","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.mehy.2013.12.019_b0080","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0002-9440(10)63505-5","article-title":"Development of autoimmune exocrinopathy resembling Sjogren\u2019s syndrome in estrogen-deficient mice of healthy background","volume":"163","author":"Ishimaru","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.mehy.2013.12.019_b0085","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1242\/jcs.034298","article-title":"Inhibitors of the V0 subunit of the vacuolar H+-ATPase prevent segregation of lysosomal- and secretory-pathway proteins","volume":"122","author":"Sobota","year":"2009","journal-title":"J Cell Sci"},{"key":"10.1016\/j.mehy.2013.12.019_b0090","first-page":"725","article-title":"Hearing loss in Sj\u00f6gren\u2019s syndrome patients. A comparative study","volume":"18","author":"Ziavra","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.mehy.2013.12.019_b0095","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/35070067","article-title":"Skp1 forms multiple protein complexes, including RAVE, a regulator of V-ATPase assembly","volume":"3","author":"Seol","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.mehy.2013.12.019_b0100","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nri1731","article-title":"Immunity by ubiquitylation: a reversible process of modification","volume":"5","author":"Liu","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.mehy.2013.12.019_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1874279301004010001","article-title":"TLR3 sensing of viral infection","volume":"4","author":"Dunlevy","year":"2010","journal-title":"Open Infect Dis J"},{"key":"10.1016\/j.mehy.2013.12.019_b0110","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1046\/j.1432-1327.2000.01421.x","article-title":"The pro- or anti-apoptotic function of NF-kappaB is determined by the nature of the apoptotic stimulus","volume":"267","author":"Kaltschmidt","year":"2000","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.mehy.2013.12.019_b0115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1158\/0008-5472.CAN-11-1484","article-title":"Defective NF-\u03baB signaling in metastatic head and neck cancer cells leads to enhanced apoptosis by double-stranded RNA","volume":"72","author":"Umemura","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.mehy.2013.12.019_b0120","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.immuni.2007.08.016","article-title":"Requirement for a Drosophila E3-ubiquitin ligase in phagocytosis of apoptotic cells","volume":"27","author":"Silva","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.mehy.2013.12.019_b0125","doi-asserted-by":"crossref","first-page":"718237","DOI":"10.1155\/2012\/718237","article-title":"Autoantigen TRIM21\/Ro52 as a possible target for treatment of systemic lupus erythematosus","volume":"2012","author":"Yoshimi","year":"2012","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.mehy.2013.12.019_b0130","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jaut.2012.01.014","article-title":"The immunobiology of Ro52 (TRIM21) in autoimmunity: a critical review","volume":"39","author":"Oke","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.mehy.2013.12.019_b0210","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1084\/jem.20090585","article-title":"Loss of the lupus autoantigen Ro52\/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway","volume":"206","author":"Espinosa","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.mehy.2013.12.019_b0140","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2796.2009.02100.x","article-title":"Autoimmune associated congenital heart block: integration of clinical and research clues in the management of the maternal\/foetal dyad at risk","volume":"265","author":"Buyon","year":"2009","journal-title":"J Intern Med"},{"key":"10.1016\/j.mehy.2013.12.019_b0145","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/rheumatology\/kei281","article-title":"Incidence of cancer in a cohort of patients with primary Sjogren\u2019s syndrome","volume":"45","author":"Lazarus","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.mehy.2013.12.019_b0150","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3960\/jslrt.49.89","article-title":"B-cell lymphoma associated with Sj\u00f6gren\u2019s syndrome among Japanese patients: a clinicopathologic and immunohistochemical study of 15 cases","volume":"49","author":"Kojima","year":"2009","journal-title":"J Clin Exp Hematop"},{"key":"10.1016\/j.mehy.2013.12.019_b0155","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1182\/blood.V90.2.766","article-title":"Lymphomas in patients with Sjogren\u2019s syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses","volume":"90","author":"Royer","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.mehy.2013.12.019_b0160","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/sj.leu.2404517","article-title":"The pathogenesis of MALT lymphomas: where do we stand?","volume":"21","author":"Sagaert","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.mehy.2013.12.019_b0165","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.it.2004.03.008","article-title":"The two NF-kappaB activation pathways and their role in innate and adaptive immunity","volume":"25","author":"Bonizzi","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.mehy.2013.12.019_b0170","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.2741\/4045","article-title":"The Fbw7 and betaTRCP E3 ubiquitin ligases and their roles in tumorigenesis","volume":"17","author":"Lau","year":"2012","journal-title":"Front Biosci"},{"key":"10.1016\/j.mehy.2013.12.019_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-9433-3-1","article-title":"Liou HC.NF-kB inhibitor blocks B cell development at two checkpoints","volume":"3","author":"Feng","year":"2004","journal-title":"Med Immunol"},{"issue":"47","key":"10.1016\/j.mehy.2013.12.019_b0180","doi-asserted-by":"crossref","first-page":"32835","DOI":"10.1074\/jbc.M109.034223","article-title":"Mandel SA.A sporadic Parkinson disease model via silencing of the ubiquitin-proteasome\/E3 ligase component SKP1A","volume":"284","author":"Fishman-Jacob","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2013.12.019_b0185","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1750-1326-7-26","article-title":"A molecular signature in blood identifies early Parkinson\u2019s disease","volume":"7","author":"Molochnikov","year":"2012","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.mehy.2013.12.019_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.envres.2013.08.001","article-title":"Pesticides that inhibit the ubiquitin-proteasome system: effect measure modification by genetic variation in SKP1in Parkinson\u2019s disease","volume":"126","author":"Rhodes","year":"2013","journal-title":"Environ Res"},{"issue":"23","key":"10.1016\/j.mehy.2013.12.019_b0195","doi-asserted-by":"crossref","first-page":"8375","DOI":"10.1128\/MCB.22.23.8375-8387.2002","article-title":"In vivo interference with Skp1 function leads to genetic instability and neoplastic transformation","volume":"22","author":"Piva","year":"2002","journal-title":"Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.mehy.2013.12.019_b0200","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2174\/156800911794519734","article-title":"SCF E3 ubiquitin ligases as anticancer targets","volume":"11","author":"Jia","year":"2011","journal-title":"Curr Cancer Drug Targets"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987714000036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987714000036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T10:33:15Z","timestamp":1648031595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987714000036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0306987714000036"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2013.12.019","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of vacuolar ATPase and Skp1 in Sj\u00f6gren\u2019s syndrome","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2013.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}